BIs are common in patients with liver cirrhosis and show a modest upward trend over time, with the highest burdens observed ...
The new programme addresses the urgent unmet medical need for new therapies to tackle antibiotic-resistant infections ...
Munich, Germany, Jan. 20, 2026 (GLOBE NEWSWIRE) -- smartbax, a biotech company developing next-generation antibiotics against ...
Cefiderocol was effective in multiple gram-negative bacterial infections, particularly in patients with complex clinical profiles and prior antibiotic exposure, with no significant difference in ...
The gut microbiome has been a rising star in the world of health science over the last several years, garnering interest from both researchers and the general public. This is mostly due to its ...
We may receive a commission on purchases made from links. Every consumer battery that exists has little plus and minus signs on the outer labeling. These mark the ending and starting points for the ...
NEW YORK – Diasorin said Saturday that it has received US Food and Drug Administration 510(k) marketing clearance for a syndromic panel to detect and identify the Gram-positive causes of bloodstream ...
Endolysins, bacteriophage-encoded peptidoglycan hydrolases, offer promising potential in antibacterial therapy, including treatments targeting gram-negative bacteria. While these enzymes naturally act ...
Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator. YidC is a membrane protein that plays an important role in inserting newly generated ...